These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16959718)

  • 1. Platelet function and pharmacologic inhibition.
    Chaer RA; Graham JA; Mureebe L
    Vasc Endovascular Surg; 2006; 40(4):261-7. PubMed ID: 16959718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets: is aspirin sufficient or must we know how to pronounce abciximab?
    Brinkman WT; Terramani TT; Najibi S; Chaikof EL
    Semin Vasc Surg; 2002 Dec; 15(4):245-55. PubMed ID: 12478499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of a factor Xa inhibitor, TAK-442, and antiplatelet agents on whole blood coagulation and arterial thrombosis in rats.
    Konishi N; Hiroe K; Kawamura M
    Thromb Res; 2010 Aug; 126(2):124-9. PubMed ID: 20452654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to antiplatelet resistance is it justified?
    Steinhubl SR; Charnigo R; Moliterno DJ
    J Am Coll Cardiol; 2005 Jun; 45(11):1757-8. PubMed ID: 15936601
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury.
    Bright JM; Dowers K; Powers BE
    Vet Ther; 2003; 4(1):35-46. PubMed ID: 12756634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS; Raizner AE; Jordan R; Wang AL; Norton D; Mace KF; Joshi A; Coller BS; Weisman HF
    J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response variability and the role of platelet function testing.
    Gurbel PA; Mahla E; Antonino MJ; Tantry US
    J Invasive Cardiol; 2009 Apr; 21(4):172-8. PubMed ID: 19342756
    [No Abstract]   [Full Text] [Related]  

  • 10. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.
    Armstrong PC; Dhanji AR; Truss NJ; Zain ZN; Tucker AT; Mitchell JA; Warner TD
    Thromb Haemost; 2009 Oct; 102(4):772-8. PubMed ID: 19806265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet reactivity on aspirin, clopidogrel and abciximab in patients with acute coronary syndromes and reduced estimated glomerular filtration rate.
    Małek LA; Bilińska ZT; Sitkiewicz D; Kłopotowski M; Witkowski A; Ruzyłło W
    Thromb Res; 2010 Jan; 125(1):67-71. PubMed ID: 19443019
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of abciximab, ticlopidine, and combined Abciximab/Ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty.
    Fredrickson BJ; Turner NA; Kleiman NS; Graziadei N; Maresh K; Mascelli MA; Effron MB; McIntire LV
    Circulation; 2000 Mar; 101(10):1122-9. PubMed ID: 10715258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets in vascular disease.
    Reinhart WH
    Clin Hemorheol Microcirc; 2013; 53(1-2):71-9. PubMed ID: 22954635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of currently used antiplatelet drugs.
    de Gaetano G; Bertele' V; Cerletti C
    Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New thoughts on strategies for modulating platelet function through the inhibition of surface receptors.
    Nurden AT
    Haemostasis; 1996 Oct; 26 Suppl 4():78-88. PubMed ID: 8979114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process.
    Hosokawa K; Ohnishi T; Fukasawa M; Kondo T; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Microvasc Res; 2012 Mar; 83(2):154-61. PubMed ID: 22166857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clopidogrel. Actions, pharmacokinetics, clinical studies].
    Wunderlich H; Beer J; Allgaier C
    Med Monatsschr Pharm; 2002 Dec; 25(12):425-9. PubMed ID: 12522913
    [No Abstract]   [Full Text] [Related]  

  • 20. A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
    Pecot CV; Fuller M; Muldowney JA; Misra S
    Tenn Med; 2009 May; 102(5):37-9. PubMed ID: 19456028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.